[L-asparaginase--first specific cytostatic].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001215:Asparaginase / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D004285:Dogs; D006801:Humans; D007942:Leukemia, Experimental / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D051381:Rats
D000970:Antineoplastic Agents; D001215:Asparaginase
L-Asparaginase--das erste spezifische Cytostaticum.